Editorial: Hallucinogens and Entactogens: Establishing a New Class of Psychotherapeutic Drugs?

Felix Müller^*, Matthew W. Johnson, Stefan Borgwardt

^*Corresponding author for this work

2 Citations (Scopus)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{b651754ce8c14a1dbf3f4783d08ab97f,

title = "Editorial: Hallucinogens and Entactogens: Establishing a New Class of Psychotherapeutic Drugs?",

author = "Felix M{\"u}ller and Johnson, {Matthew W.} and Stefan Borgwardt",

year = "2020",

month = may,

day = "28",

doi = "10.3389/fpsyt.2020.00497",

language = "English",

volume = "11",

journal = "Frontiers in Psychiatry",

issn = "1664-0640",

}

TY - JOUR

T1 - Editorial

T2 - Hallucinogens and Entactogens: Establishing a New Class of Psychotherapeutic Drugs?

AU - Müller, Felix

AU - Johnson, Matthew W.

AU - Borgwardt, Stefan

PY - 2020/5/28

Y1 - 2020/5/28

UR - http://www.scopus.com/inward/record.url?scp=85086825347&partnerID=8YFLogxK

U2 - 10.3389/fpsyt.2020.00497

DO - 10.3389/fpsyt.2020.00497

M3 - Editorial

AN - SCOPUS:85086825347

SN - 1664-0640

VL - 11

JO - Frontiers in Psychiatry

JF - Frontiers in Psychiatry

M1 - 497

ER -